Inthera Bioscience

Scroll
Investment area
Novo Seeds
Region
Europe
Date of investment
January 2015
Website
http://intherabio.com

Inthera Bioscience is a Swiss biotech company targeting HPV+ head and neck cancer (HNSCO) and/or HPV+ genitourinary cancer as initial indication(s). 

Novo Holdings uses cookies to ensure that we give you the best experience on our website. Read more